IBDEI1M2 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,354,0)
 ;;=CONSULTATIONS^3^35
 ;;^UTILITY(U,$J,358.4,355,0)
 ;;=ESOPHAGUS^4^36
 ;;^UTILITY(U,$J,358.4,356,0)
 ;;=COLON^3^36
 ;;^UTILITY(U,$J,358.4,357,0)
 ;;=LIVER^6^36
 ;;^UTILITY(U,$J,358.4,358,0)
 ;;=PANCREAS^8^36
 ;;^UTILITY(U,$J,358.4,359,0)
 ;;=SMALL INTESTINE^11^36
 ;;^UTILITY(U,$J,358.4,360,0)
 ;;=STOMACH^12^36
 ;;^UTILITY(U,$J,358.4,361,0)
 ;;=POST SURGERY STATES^9^36
 ;;^UTILITY(U,$J,358.4,362,0)
 ;;=SYMPTOMS^14^36
 ;;^UTILITY(U,$J,358.4,363,0)
 ;;=SCREENING^10^36
 ;;^UTILITY(U,$J,358.4,364,0)
 ;;=BILIARY^2^36
 ;;^UTILITY(U,$J,358.4,365,0)
 ;;=COMOBIDITIES^15^36
 ;;^UTILITY(U,$J,358.4,366,0)
 ;;=ANORECTAL^1^36
 ;;^UTILITY(U,$J,358.4,367,0)
 ;;=INFLAMMATORY BOWEL DISEASE^5^36
 ;;^UTILITY(U,$J,358.4,368,0)
 ;;=OTHER^7^36
 ;;^UTILITY(U,$J,358.4,369,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^13^36
 ;;^UTILITY(U,$J,358.4,370,0)
 ;;=EGD^3^37
 ;;^UTILITY(U,$J,358.4,371,0)
 ;;=SMALL INTESTINE ENDOSCOPY^14^37
 ;;^UTILITY(U,$J,358.4,372,0)
 ;;=SIGMOIDOSCOPY^13^37
 ;;^UTILITY(U,$J,358.4,373,0)
 ;;=COLONOSCOPY^2^37
 ;;^UTILITY(U,$J,358.4,374,0)
 ;;=ERCP^4^37
 ;;^UTILITY(U,$J,358.4,375,0)
 ;;=G-TUBE^6^37
 ;;^UTILITY(U,$J,358.4,376,0)
 ;;=MISCELLANEOUS^9^37
 ;;^UTILITY(U,$J,358.4,377,0)
 ;;=IMMUNIZATION^7^37
 ;;^UTILITY(U,$J,358.4,378,0)
 ;;=MOTILITY^11^37
 ;;^UTILITY(U,$J,358.4,379,0)
 ;;=EUS^5^37
 ;;^UTILITY(U,$J,358.4,380,0)
 ;;=LIVER^8^37
 ;;^UTILITY(U,$J,358.4,381,0)
 ;;=MODERATE SEDATION^10^37
 ;;^UTILITY(U,$J,358.4,382,0)
 ;;=MOST COMMONLY USED^1^37
 ;;^UTILITY(U,$J,358.4,383,0)
 ;;=PROLONGED SERVICES^12^37
 ;;^UTILITY(U,$J,358.4,384,0)
 ;;=NEW PATIENT HOME VISIT^2^38
 ;;^UTILITY(U,$J,358.4,385,0)
 ;;=ESTAB PATIENT HOME VISIT^1^38
 ;;^UTILITY(U,$J,358.4,386,0)
 ;;=PC COMMON DIAGNOSES^1^39
 ;;^UTILITY(U,$J,358.4,387,0)
 ;;=ADMINISTRATIVE TOPICS^15^39
 ;;^UTILITY(U,$J,358.4,388,0)
 ;;=ANGINA^16^39
 ;;^UTILITY(U,$J,358.4,389,0)
 ;;=ATHEROSCLEROSIS^17^39
 ;;^UTILITY(U,$J,358.4,390,0)
 ;;=CARDIOVASCULAR^18^39
 ;;^UTILITY(U,$J,358.4,391,0)
 ;;=DERMATOLOGY^22^39
 ;;^UTILITY(U,$J,358.4,392,0)
 ;;=EAR DISORDERS^24^39
 ;;^UTILITY(U,$J,358.4,393,0)
 ;;=EENT^25^39
 ;;^UTILITY(U,$J,358.4,394,0)
 ;;=ENDOCRINE/METABOLIC^26^39
 ;;^UTILITY(U,$J,358.4,395,0)
 ;;=EYE DISORDERS^27^39
 ;;^UTILITY(U,$J,358.4,396,0)
 ;;=EYE INJURY^28^39
 ;;^UTILITY(U,$J,358.4,397,0)
 ;;=GASTROENTEROLOGY^29^39
 ;;^UTILITY(U,$J,358.4,398,0)
 ;;=GU/RENAL^30^39
 ;;^UTILITY(U,$J,358.4,399,0)
 ;;=HEADACHE^31^39
 ;;^UTILITY(U,$J,358.4,400,0)
 ;;=HEART VALVE DISEASE^32^39
 ;;^UTILITY(U,$J,358.4,401,0)
 ;;=HEMATOLOGY/ONCOLOGY^33^39
 ;;^UTILITY(U,$J,358.4,402,0)
 ;;=HISTORY OF ILLNESS^34^39
 ;;^UTILITY(U,$J,358.4,403,0)
 ;;=INFECTIOUS DISEASE^35^39
 ;;^UTILITY(U,$J,358.4,404,0)
 ;;=LIVER DISEASE^36^39
 ;;^UTILITY(U,$J,358.4,405,0)
 ;;=MENTAL HEALTH^38^39
 ;;^UTILITY(U,$J,358.4,406,0)
 ;;=MOVEMENT DISORDERS^39^39
 ;;^UTILITY(U,$J,358.4,407,0)
 ;;=MUSCULOSKELETAL^40^39
 ;;^UTILITY(U,$J,358.4,408,0)
 ;;=NEUROLOGY^41^39
 ;;^UTILITY(U,$J,358.4,409,0)
 ;;=PAIN^42^39
 ;;^UTILITY(U,$J,358.4,410,0)
 ;;=PREVENTIVE HEALTH^43^39
 ;;^UTILITY(U,$J,358.4,411,0)
 ;;=PULMONARY^44^39
 ;;^UTILITY(U,$J,358.4,412,0)
 ;;=SEXUAL TRAUMA^45^39
 ;;^UTILITY(U,$J,358.4,413,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^39
 ;;^UTILITY(U,$J,358.4,414,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^39
 ;;^UTILITY(U,$J,358.4,415,0)
 ;;=SUBSTANCE DISORDERS^48^39
 ;;^UTILITY(U,$J,358.4,416,0)
 ;;=VARICOSE VEINS^50^39
